JERI TOWNSEND: Open Payments
NPI 1407818420 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 46 payments from 13 companies in 2025. Trend: 2023 $698 · 2024 $791 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $185 |
| Collegium Pharmaceutical, Inc. | 9 | $141 |
| Averitas Pharma Inc. | 9 | $130 |
| ABBVIE INC. | 6 | $120 |
| Valinor Pharma, LLC | 3 | $38 |
| AppliedVR Inc | 2 | $35 |
| Boston Scientific Corporation | 1 | $32 |
| Globus Medical, Inc. | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Braeburn Inc. | 1 | $21 |
Products named: RELISTOR, Belbuca, QUTENZA, BOTOX, MOVANTIK, RelieVRx, Intracept, Senza.
Industry payments across OK — which companies pay providers there.
